GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dongsung Pharmaceutical Co Ltd (XKRX:002210) » Definitions » Research & Development

Dongsung Pharmaceutical Co (XKRX:002210) Research & Development : ₩4,169 Mil (TTM As of Dec. 2023)


View and export this data going back to 1990. Start your Free Trial

What is Dongsung Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Dongsung Pharmaceutical Co's Research & Development for the three months ended in Dec. 2023 was ₩1,017 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,169 Mil.


Dongsung Pharmaceutical Co Research & Development Historical Data

The historical data trend for Dongsung Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dongsung Pharmaceutical Co Research & Development Chart

Dongsung Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,104.42 3,373.32 3,395.33 4,115.81 4,169.12

Dongsung Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,005.76 1,065.81 1,145.57 940.77 1,016.96

Dongsung Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,169 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dongsung Pharmaceutical Co  (XKRX:002210) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Dongsung Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Dongsung Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Dongsung Pharmaceutical Co (XKRX:002210) Business Description

Traded in Other Exchanges
N/A
Address
Dobong 683, Seoul, KOR, 132-020
Dongsung Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture and distribution of hair dyes, cosmetics and pharmaceutical products.

Dongsung Pharmaceutical Co (XKRX:002210) Headlines

No Headlines